{"patient_id": 26798, "patient_uid": "7577305-3", "PMID": 33101806, "file_path": "comm/PMC007xxxxxx/PMC7577305.xml", "title": "Subcutaneous Emphysema in Patients With COVID-19 Infection: A Report of Three Cases", "patient": "A 30-year-old female presented to the ER after five days of dry cough, sore throat, fever, worsening shortness of breath, and multiple episodes of diarrhea. The patient was diagnosed with type 1 DM since age 13 years and never smoked. On arrival, she was hypoxic with initial improvement on NC 6 L/minute but overnight required HFNC at 40 L/minute and O2 at 100%. Her CXR showed bilateral multifocal infiltrates. Her SARS-CoV-2 test was positive. The patient required intubation due to impending respiratory failure one day after she was admitted.\\nShe was treated with azithromycin and IV methylprednisolone for four days, hydroxychloroquine for five days, ceftriaxone for three days, cefepime for five days, piperacillin/tazobactam for seven days, fluconazole for five days, and micafungin for seven days. Other treatment included one dose of tocilizumab (Actemra\u00ae) and one unit of COVID convalescent plasma transfusion.\\nThe patient was found to have a new SE in the right side of the neck on day 9 of hospital admission on ventilator settings: VC mode, RR: 25 bpm, TV: 350 cc, FiO2: 60%, PEEP: 14 cmH2O. A CXR confirmed the findings (Figure ), it resolved with no need for chest tube placement after seven days. The patient had a prolonged intubation course and underwent tracheostomy on day 28 of hospitalization. The patient was eventually discharged on day 63 of admission.", "age": "[[30.0, 'year']]", "gender": "F", "relevant_articles": "{'32007143': 1, '24175278': 1, '32474632': 1, '32091414': 1, '24834397': 1, '33101806': 2}", "similar_patients": "{'7577305-1': 2, '7577305-2': 2}"}